Company: LIN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060925
Chunk: 17

Company: LINDE PLC
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 17
---
 determining whether to approve or ratify a transaction or relationship, the Audit Committee considers, among other factors, whether the matter would constitute a violation of the conflicts of interest provisions of the Company’s Ethics Policy, whether the matter would violate the Nasdaq listing standards, the expected practical impact of the transaction or relationship on the individual’s

independence of judgment or ability to act in the best interests of the Company, the availability, practicality and effectiveness of mitigating controls or safeguards such as recusal, restricted access to information, reassignment etc., and the best interests of the Company and its shareholders generally.

Application of Policies & Procedures.During 2024, no actual or potential conflicts of interest were identified with respect to the executive officers and directors of the Company.

Certain Relationships and Transactions

When determining whether any director or nominee is independent, the Board considers all facts and circumstances and any relationships that a director or nominee may have with the Company, directly or indirectly, other than in the capacity of serving as a director. To assist the Board in making independence determinations, it also applies the independence standards which are posted at Linde’s public website, www.linde.com in the About Us/Corporate Governance section. In February 2025, the Board considered the following circumstances and relationships of those directors and nominees who then had any direct or indirect relationship with the Company.

In the ordinary course of its business, Linde sells industrial gases to, and purchases certain goods or services from, E. ON SE, of which Dr. Victoria Ossadnik is an executive officer. The 2024 consolidated revenues for each of Linde and E.ON SE were $33.0 billion and€90.5 billion, respectively. For the 2022, 2023 and 2024 fiscal years, the dollar value of Linde’s sales to, or purchases from, E.ON SE were $0.2 million, $0.7 million and $0.4 million in sales, respectively and $.08 million, $1.0 million and $0.9 million of purchases, respectively. Such sale and purchase transactions were well below the limits set forth in the Board’s independence standards and were significantly less than 1% of the consolidated revenues of Linde or E.ON SE. Therefore, the Board has determined that such ordinary course business relationships are not material and do not otherwise impair the ability of Dr. Ossadnik to exercise independent judgment as a director.

Insider Trading Policy and Procedures

Linde hasadoptedan insider trading